Jade Biosciences JBIO
NASDAQ JBIO
$15.14 +0.28 (+1.88%)
As of: Oct 21, 2026 · 3:54 PM EDT

Jade Biosciences (JBIO) Other financing activities (2021 - 2026)

Updated

Jade Biosciences' Other financing activities was $840,000 in Q1 2026.

Analysis

Jade Biosciences (JBIO) Other financing activities (2021 - 2026) Analysis & Trends

For FY2025, Other financing activities at Jade Biosciences came in at $189.11 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 Jade Biosciences 926.52 Mn -381.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -840,000.00
Dec 31, 2025 -1.34 Mn
Jun 30, 2025 191.31 Mn
Mar 31, 2025 -700,000.00
Sep 30, 2024 -228,000.00
Jun 30, 2024 -74,000.00
Mar 31, 2024 -233,000.00
Sep 30, 2023 -75,000.00
Dec 31, 2022 -236,000.00
Jun 30, 2021 -1.02 Mn
Mar 31, 2021 -100,000.00
API Access

Jade Biosciences Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=JBIO&period=max&api_key=YOUR_API_KEY